SAMANTHA NEUHAUS: Open Payments
NPI 1497478812 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,000 in 134 payments from 26 companies in 2025. Trend: 2023 $19 · 2024 $576 · 2025 $3,000
Food & beverage: $3,000
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $323 |
| UCB, Inc. | 10 | $295 |
| SK Life Science, Inc. | 10 | $261 |
| ARGENX US, INC. | 8 | $258 |
| PFIZER INC. | 18 | $243 |
| Novartis Pharmaceuticals Corporation | 9 | $216 |
| ACADIA Pharmaceuticals Inc | 7 | $180 |
| Biogen, Inc. | 5 | $109 |
| Neurelis, Inc. | 2 | $108 |
| Merz Pharmaceuticals, LLC | 3 | $104 |
Products named: NURTEC ODT, Rystiggo, KESIMPTA, NUPLAZID, QULIPTA, VYVGART, REXULTI, VYVGART HYTRULO.
Industry payments across MS — which companies pay providers there.
